MedPath

A Post-market, Observational Registry With the easyEndoTM Universal Linear Cutting Stapler in Laparoscopic Bariatric Surgery

Active, not recruiting
Conditions
Gastrectomy
Mini Gastric Bypass
Obesity
Roux-en-Y Gastric Bypass
Interventions
Device: easyEndoTM Universal Linear Cutting Stapler and reloads (Ezisurg Medical)
Registration Number
NCT04422236
Lead Sponsor
Duomed
Brief Summary

The purpose of this observational registry is to evaluate the safety and performance of the easyEndoTM Universal Linear Cutting Stapler and reloads from Ezisurg Medical when used to create anastomoses during laparoscopic bariatric surgery. The goal of the study will be achieved by assessing the device performance and by reporting of peri- and postoperative complications in a prospectively maintained database.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patient ≥ 18 years of age at registry entry.
  • Patient and investigator signed and dated the informed consent form prior to the index-procedure.
  • Patient has a BMI ≥ 35 kg/m2, with one or more related co-morbidities.
  • Patient has a BMI ≥ 40 kg/m2.
  • Patient is eligible for laparoscopic bariatric surgery.
Exclusion Criteria
  • Patient is unable / unwilling to provide informed consent.
  • Patient has a history of bariatric surgery.
  • Patient is unable to comply with the registry protocol or proposed follow-up visits.
  • Patient has a contra-indication for laparoscopic bariatric surgery.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Obese patients eligible for laparoscopic bariatric surgeryeasyEndoTM Universal Linear Cutting Stapler and reloads (Ezisurg Medical)-
Primary Outcome Measures
NameTimeMethod
To evaluate the safety of the easyEndoTM Universal Linear Cutting Stapler and reloads (Ezisurg Medical) in laparoscopic bariatric surgery.Follow-up 6: 24 months after the procedure

Number of re-interventions and number of participants with (serious) adverse events ≥ grade II Clavien-Dindo.

Secondary Outcome Measures
NameTimeMethod
Device performanceAt index procedure

Assessment of device performance (e.g. sharpness of the blade, staple-line formation, etc.).

Clinical efficacyFollow-up 6: 24 months after the procedure

Comorbidity

Trial Locations

Locations (1)

AZ Delta vzw

🇧🇪

Roeselare, Belgium

© Copyright 2025. All Rights Reserved by MedPath